2022 Q3 Form 10-Q Financial Statement
#000156459022029497 Filed on August 15, 2022
Income Statement
| Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $1.102M | $973.9K | $612.9K |
| YoY Change | 670.55% | 2624.06% | |
| % of Gross Profit | |||
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | |||
| YoY Change | |||
| % of Gross Profit | |||
| Operating Expenses | $1.102M | $973.9K | $612.9K |
| YoY Change | 670.55% | 2624.06% | |
| Operating Profit | -$1.102M | -$973.9K | -$612.9K |
| YoY Change | 670.54% | ||
| Interest Expense | $5.184K | $300.1K | $17.51K |
| YoY Change | 3887.69% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | $31.80K | $127.2K | $230.6K |
| YoY Change | -151.83% | ||
| Pretax Income | -$106.9K | -$546.5K | -$364.8K |
| YoY Change | -47.66% | 1428.7% | 920.5% |
| Income Tax | $288.9K | $89.56K | $5.115K |
| % Of Pretax Income | |||
| Net Earnings | -$395.8K | -$636.1K | -$369.9K |
| YoY Change | 93.79% | 934.81% | |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | -$0.16 | -$0.13 | -$0.06 |
| Diluted Earnings Per Share | -$13.40K | -$21.53K | -$12.56K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 29.55M | 6.540M | 6.540M |
| Diluted Shares Outstanding | 6.540M | 6.540M | 6.540M |
Balance Sheet
| Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $485.7K | $55.16K | $192.1K |
| YoY Change | -76.33% | ||
| Cash & Equivalents | $485.7K | $55.16K | $192.1K |
| Short-Term Investments | |||
| Other Short-Term Assets | $359.3K | $530.2K | $715.6K |
| YoY Change | -50.47% | ||
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $845.0K | $585.4K | $907.7K |
| YoY Change | -69.57% | ||
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | |||
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $40.87M | $232.6M | $232.3M |
| YoY Change | -82.41% | ||
| Other Assets | $0.00 | $0.00 | |
| YoY Change | -100.0% | ||
| Total Long-Term Assets | $40.87M | $232.6M | $232.3M |
| YoY Change | -82.43% | ||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $845.0K | $585.4K | $907.7K |
| Total Long-Term Assets | $40.87M | $232.6M | $232.3M |
| Total Assets | $41.72M | $233.2M | $233.2M |
| YoY Change | -82.28% | ||
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $230.7K | $278.3K | $208.2K |
| YoY Change | -81.19% | ||
| Accrued Expenses | $1.196M | $769.9K | $355.0K |
| YoY Change | 311.15% | ||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $836.8K | $431.6K | $262.2K |
| YoY Change | 9687.6% | ||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $2.646M | $1.573M | $832.3K |
| YoY Change | 73.37% | ||
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $9.224M | $9.256M | $9.383M |
| YoY Change | -4.36% | ||
| Total Long-Term Liabilities | $9.224M | $9.256M | $9.383M |
| YoY Change | -4.36% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $2.646M | $1.573M | $832.3K |
| Total Long-Term Liabilities | $9.224M | $9.256M | $9.383M |
| Total Liabilities | $11.87M | $10.83M | $10.22M |
| YoY Change | 6.26% | ||
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$11.03M | -$10.15M | |
| YoY Change | 37.01% | ||
| Common Stock | $655.00 | $655.00 | |
| YoY Change | 0.0% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$11.02M | -$10.15M | -$9.301M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $41.72M | $233.2M | $233.2M |
| YoY Change | -82.28% |
Cashflow Statement
| Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$395.8K | -$636.1K | -$369.9K |
| YoY Change | 93.79% | 934.81% | |
| Depreciation, Depletion And Amortization | |||
| YoY Change | |||
| Cash From Operating Activities | -$292.7K | -$136.9K | -$229.5K |
| YoY Change | 1034.5% | ||
| INVESTING ACTIVITIES | |||
| Capital Expenditures | |||
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $192.7M | ||
| YoY Change | -182.96% | ||
| Cash From Investing Activities | $192.7M | ||
| YoY Change | -182.96% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -192.0M | 0.000 | 0.000 |
| YoY Change | -181.92% | -100.0% | |
| NET CHANGE | |||
| Cash From Operating Activities | -292.7K | -136.9K | -229.5K |
| Cash From Investing Activities | 192.7M | ||
| Cash From Financing Activities | -192.0M | 0.000 | 0.000 |
| Net Change In Cash | 430.5K | -136.9K | -229.5K |
| YoY Change | -79.02% | -607.5% | |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$292.7K | -$136.9K | -$229.5K |
| Capital Expenditures | |||
| Free Cash Flow | |||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| gia |
Number Of Trading Period For Transfer Of Shares
NumberOfTradingPeriodForTransferOfShares
|
P20D | ||
| gia |
Number Of Consecutive Trading Period For Transfer Of Shares
NumberOfConsecutiveTradingPeriodForTransferOfShares
|
P30D | ||
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6540000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8735000 | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6540000 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7180920 | ||
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
||
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1586735 | ||
| CY2022Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
127200 | |
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
357750 | ||
| us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
317653 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-911332 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-35749 | ||
| CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
89562 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
94677 | ||
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-636074 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1006009 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-35749 | ||
| CY2022Q2 | gia |
Net Income Loss Attributable To Common Stock Subject To Redemption
NetIncomeLossAttributableToCommonStockSubjectToRedemption
|
210578 | |
| gia |
Net Income Loss Attributable To Common Stock Subject To Redemption
NetIncomeLossAttributableToCommonStockSubjectToRedemption
|
222976 | ||
| CY2022Q2 | gia |
Weighted Average Number Of Share Outstanding Subject To Possible Redemption Basic And Diluted
WeightedAverageNumberOfShareOutstandingSubjectToPossibleRedemptionBasicAndDiluted
|
23000000 | |
| gia |
Weighted Average Number Of Share Outstanding Subject To Possible Redemption Basic And Diluted
WeightedAverageNumberOfShareOutstandingSubjectToPossibleRedemptionBasicAndDiluted
|
23000000 | ||
| CY2022Q2 | gia |
Earnings Per Share Subject To Possible Redemption Basic And Diluted
EarningsPerShareSubjectToPossibleRedemptionBasicAndDiluted
|
0.01 | |
| gia |
Earnings Per Share Subject To Possible Redemption Basic And Diluted
EarningsPerShareSubjectToPossibleRedemptionBasicAndDiluted
|
0.01 | ||
| CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-846652 | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1228985 | ||
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-35749 | ||
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6540000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8735000 | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6540000 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7180920 | ||
| CY2022Q2 | gia |
Earnings Per Share Non Redeemable Common Stock Basic And Diluted
EarningsPerShareNonRedeemableCommonStockBasicAndDiluted
|
-0.13 | |
| gia |
Earnings Per Share Non Redeemable Common Stock Basic And Diluted
EarningsPerShareNonRedeemableCommonStockBasicAndDiluted
|
-0.19 | ||
| gia |
Earnings Per Share Non Redeemable Common Stock Basic And Diluted
EarningsPerShareNonRedeemableCommonStockBasicAndDiluted
|
0.00 | ||
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9300571 | |
| CY2022Q2 | gia |
Temporary Equity Shares Subject To Redemption Value
TemporaryEquitySharesSubjectToRedemptionValue
|
210578 | |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-636074 | |
| CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10147223 | |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10749 | |
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10749 | |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8918238 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-35749 | ||
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10749 | |
| us-gaap |
Profit Loss
ProfitLoss
|
-1006009 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-35749 | ||
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-357750 | ||
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-210033 | ||
| us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-165230 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
165179 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
25749 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
324016 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
10000 | ||
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
91777 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-366391 | ||
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | ||
| us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
125000 | ||
| us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
104788 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
45212 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-366391 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
45212 | ||
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
421549 | |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
55158 | |
| CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
45212 | |
| gia |
Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
|
222976 | ||
| gia |
Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
|
85000 | ||
| gia |
Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
|
13482 | ||
| gia |
Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
|
129951 | ||
| dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2021-01-19 | ||
| CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q3 | gia |
Number Of Shares Of Common Stock Per Unit
NumberOfSharesOfCommonStockPerUnit
|
1 | |
| CY2021Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.50 | |
| CY2021Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
23000000 | |
| CY2021Q3 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
10.00 | |
| CY2021Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
225400000 | |
| CY2021Q3 | gia |
Payments Of Stock Issuance Costs Net
PaymentsOfStockIssuanceCostsNet
|
13193740 | |
| CY2021Q3 | gia |
Deferred Underwriting Fees
DeferredUnderwritingFees
|
9200000 | |
| CY2021Q3 | gia |
Original Offering Cost
OriginalOfferingCost
|
843740 | |
| CY2021Q3 | gia |
Reimbursement Of Offering Expenses
ReimbursementOfOfferingExpenses
|
1450000 | |
| us-gaap |
Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
|
U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less | ||
| us-gaap |
Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
|
The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes none of the funds held in the Trust Account will be released until the earlier of: (1) the completion of the Business Combination; (2) the redemption of 100% of the outstanding Public Shares if the Company has not completed an initial Business Combination within 12 months from the closing of the Offering (or up to 18 months in total if the Company extends the period of time to consummate its initial Business Combination up to six times by an additional one month each time; provided that at the beginning of each one-month extension, the Sponsor (or its designees) must deposit into the Trust Account funds equal to thirty-three hundredths of one percent (0.33%) of the gross proceeds of the Offering (including such proceeds from the exercise of the Underwriters’ over-allotment option) for each one-month extension of the time period to complete the initial Business Combination, in each case, in exchange for a non-interest bearing, unsecured promissory note); or (3) the redemption of any Public Shares properly tendered in connection with a stockholder vote to amend the amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the Company’s Public Shares if the Company does not complete its initial Business Combination within the required time period or (B) with respect to any other provision relating to the Company’s pre-business combination activity and related stockholders’ rights. | ||
| gia |
Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
|
1 | ||
| gia |
Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
|
1 | ||
| gia |
Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
|
0.80 | ||
| CY2022Q2 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
225400000 | |
| us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
23000000 | ||
| CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
10.00 | |
| CY2022Q2 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
158838 | |
| CY2021Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
1973 | |
| gia |
Common Stock Redemption Percentage
CommonStockRedemptionPercentage
|
0.15 | ||
| CY2022Q2 | us-gaap |
Cash
Cash
|
55158 | |
| CY2022Q2 | us-gaap |
Cumulative Earnings Deficit
CumulativeEarningsDeficit
|
988033 | |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> | ||
| us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
13193740 | ||
| CY2022Q2 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares
|
23000000 | |
| CY2021Q4 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares
|
23000000 | |
| CY2022Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2022Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
| CY2021Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
| gia |
Holding Period Of Shares For Completion Of Initial Business Combination
HoldingPeriodOfSharesForCompletionOfInitialBusinessCombination
|
P6M | ||
| gia |
Period After Completion Of Business Combination To Allow Transfer Of Shares
PeriodAfterCompletionOfBusinessCombinationToAllowTransferOfShares
|
P30D | ||
| gia |
Underwriting Discount Per Public Unit Paid In Cash
UnderwritingDiscountPerPublicUnitPaidInCash
|
0.20 | ||
| gia |
Deferred Underwriting Commissions Per Public Unit
DeferredUnderwritingCommissionsPerPublicUnit
|
0.40 | ||
| CY2022Q2 | gia |
Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
|
9200000 | |
| CY2022Q2 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
158838 | |
| CY2021Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
1973 | |
| CY2022Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
431643 | |
| CY2021Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
72857 |
